JP2018518937A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018518937A5 JP2018518937A5 JP2017548292A JP2017548292A JP2018518937A5 JP 2018518937 A5 JP2018518937 A5 JP 2018518937A5 JP 2017548292 A JP2017548292 A JP 2017548292A JP 2017548292 A JP2017548292 A JP 2017548292A JP 2018518937 A5 JP2018518937 A5 JP 2018518937A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- peptide
- cell
- cancer
- variant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021087277A JP7525442B2 (ja) | 2015-04-24 | 2021-05-24 | Ｎｓｃｌｃをはじめとする肺がんおよびその他のがんに対する免疫療法において使用するための新規ペプチドおよびペプチド組み合わせ |
| JP2024034009A JP2024069322A (ja) | 2015-04-24 | 2024-03-06 | Ｎｓｃｌｃをはじめとする肺がんおよびその他のがんに対する免疫療法において使用するための新規ペプチドおよびペプチド組み合わせ |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562152258P | 2015-04-24 | 2015-04-24 | |
| US62/152,258 | 2015-04-24 | ||
| GB1507030.3 | 2015-04-24 | ||
| GBGB1507030.3A GB201507030D0 (en) | 2015-04-24 | 2015-04-24 | Immunotherapy against lung cancers, in particular NSCLC |
| PCT/EP2016/059053 WO2016170139A1 (en) | 2015-04-24 | 2016-04-22 | Novel peptides and combination of peptides for use in immunotherapy against lung cancer, including nsclc and other cancers |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021087277A Division JP7525442B2 (ja) | 2015-04-24 | 2021-05-24 | Ｎｓｃｌｃをはじめとする肺がんおよびその他のがんに対する免疫療法において使用するための新規ペプチドおよびペプチド組み合わせ |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018518937A JP2018518937A (ja) | 2018-07-19 |
| JP2018518937A5 true JP2018518937A5 (https=) | 2019-04-11 |
| JP6901065B2 JP6901065B2 (ja) | 2021-07-14 |
Family
ID=53488628
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017548292A Expired - Fee Related JP6901065B2 (ja) | 2015-04-24 | 2016-04-22 | Ｎｓｃｌｃをはじめとする肺がんおよびその他のがんに対する免疫療法において使用するための新規ペプチドおよびペプチド組み合わせ |
| JP2021087277A Active JP7525442B2 (ja) | 2015-04-24 | 2021-05-24 | Ｎｓｃｌｃをはじめとする肺がんおよびその他のがんに対する免疫療法において使用するための新規ペプチドおよびペプチド組み合わせ |
| JP2024034009A Pending JP2024069322A (ja) | 2015-04-24 | 2024-03-06 | Ｎｓｃｌｃをはじめとする肺がんおよびその他のがんに対する免疫療法において使用するための新規ペプチドおよびペプチド組み合わせ |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021087277A Active JP7525442B2 (ja) | 2015-04-24 | 2021-05-24 | Ｎｓｃｌｃをはじめとする肺がんおよびその他のがんに対する免疫療法において使用するための新規ペプチドおよびペプチド組み合わせ |
| JP2024034009A Pending JP2024069322A (ja) | 2015-04-24 | 2024-03-06 | Ｎｓｃｌｃをはじめとする肺がんおよびその他のがんに対する免疫療法において使用するための新規ペプチドおよびペプチド組み合わせ |
Country Status (27)
| Country | Link |
|---|---|
| US (16) | US10925948B2 (https=) |
| EP (5) | EP3750559A1 (https=) |
| JP (3) | JP6901065B2 (https=) |
| KR (1) | KR20170137119A (https=) |
| CN (4) | CN107624118B (https=) |
| AR (1) | AR104675A1 (https=) |
| AU (6) | AU2016251621B2 (https=) |
| BR (1) | BR112017017560A2 (https=) |
| CA (1) | CA2983064A1 (https=) |
| CL (8) | CL2017001819A1 (https=) |
| CO (1) | CO2017008902A2 (https=) |
| EA (1) | EA201792044A1 (https=) |
| GB (1) | GB201507030D0 (https=) |
| HK (1) | HK1244666A1 (https=) |
| IL (2) | IL292411A (https=) |
| MA (5) | MA51763A (https=) |
| MX (2) | MX2017013688A (https=) |
| MY (1) | MY173099A (https=) |
| NZ (1) | NZ734197A (https=) |
| PE (2) | PE20230768A1 (https=) |
| PH (1) | PH12017501275A1 (https=) |
| RU (2) | RU2723092C2 (https=) |
| SG (2) | SG11201704966YA (https=) |
| TW (2) | TWI737605B (https=) |
| UA (1) | UA122675C2 (https=) |
| WO (1) | WO2016170139A1 (https=) |
| ZA (1) | ZA201704939B (https=) |
Families Citing this family (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201511546D0 (en) | 2015-07-01 | 2015-08-12 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers |
| MA54884A (fr) | 2015-07-01 | 2022-01-12 | Immatics Biotechnologies Gmbh | Neuartige peptide und kombination aus peptiden zur verwendung in der immuntherapie gegen ovarialkarzinom und andere karzinome |
| MY189596A (en) * | 2015-07-15 | 2022-02-18 | Immatics Biotechnologies Gmbh | A novel peptides for use in immunotherapy against epithelial ovarian cancer and other cancers |
| PH12022551111A1 (en) | 2015-10-05 | 2023-08-23 | Immatics Biotechnologies Gmbh | Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers |
| ES2970865T3 (es) | 2015-12-16 | 2024-05-31 | Gritstone Bio Inc | Identificación, fabricación y uso de neoantígenos |
| CN109072219B (zh) | 2015-12-28 | 2024-02-27 | 北海道公立大学法人札幌医科大学 | 肿瘤抗原肽 |
| GB201604490D0 (en) * | 2016-03-16 | 2016-04-27 | Immatics Biotechnologies Gmbh | Peptides combination of peptides for use in immunotherapy against cancers |
| GB201609193D0 (en) | 2016-05-25 | 2016-07-06 | Immatics Biotechnologies Gmbh | Novel peptides, combination of peptides as targets for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers |
| JP7075125B2 (ja) | 2016-05-25 | 2022-05-25 | イマティクス バイオテクノロジーズ ゲーエムベーハー | 標的としてのおよび胆嚢がんおよび胆管がんおよびその他のがんに対する免疫療法で使用するための新規ペプチド、ペプチド組み合わせ |
| TWI796299B (zh) | 2016-08-26 | 2023-03-21 | 德商英麥提克生物技術股份有限公司 | 用於頭頸鱗狀細胞癌和其他癌症免疫治療的新型肽和支架 |
| DE102016123893A1 (de) | 2016-12-08 | 2018-06-14 | Immatics Biotechnologies Gmbh | T-Zellrezeptoren mit verbesserter Bindung |
| KR102379955B1 (ko) | 2016-12-08 | 2022-03-29 | 이매틱스 바이오테크놀로지스 게엠베하 | 짝짓기가 향상된 t 세포 수용체 |
| BR112019020959A2 (pt) * | 2017-04-10 | 2020-05-05 | Immatics Biotechnologies Gmbh | peptídeos e combinações dos mesmos para uso na imunoterapia contra câncer |
| WO2018189148A1 (en) * | 2017-04-10 | 2018-10-18 | Immatics Biotechnologies Gmbh | Peptides and combination thereof for use in the immunotherapy against cancers |
| EA201992416A1 (ru) | 2017-04-10 | 2020-02-25 | Имматикс Байотекнолоджиз Гмбх | Пептиды и комбинации пептидов для применения в иммунотерапии лейкозов и других видов рака |
| SG11201909058WA (en) | 2017-04-10 | 2019-10-30 | Immatics Biotechnologies Gmbh | Peptides and combination of peptides for use in immunotherapy against leukemias and other cancers |
| US10800823B2 (en) * | 2017-07-07 | 2020-10-13 | Immatics Biotechnologies Gmbh | Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers |
| DE102017115966A1 (de) | 2017-07-14 | 2019-01-17 | Immatics Biotechnologies Gmbh | Polypeptidmolekül mit verbesserter zweifacher Spezifität |
| LT3428194T (lt) | 2017-07-14 | 2021-12-10 | Immatics Biotechnologies Gmbh | Pagerinta dvejopo savitumo polipeptido molekulė |
| EP4576103A3 (en) | 2017-10-10 | 2025-08-27 | Gritstone bio, Inc. | Neoantigen identification using hotspots |
| CN111630602A (zh) | 2017-11-22 | 2020-09-04 | 磨石肿瘤生物技术公司 | 减少新抗原的接合表位呈递 |
| KR20220098056A (ko) * | 2018-02-09 | 2022-07-08 | 제넨테크, 인크. | 비만 세포 매개 염증성 질환에 대한 치료 및 진단 방법 |
| TW202016131A (zh) * | 2018-05-16 | 2020-05-01 | 德商英麥提克生物技術股份有限公司 | 用於抗癌免疫治療的肽 |
| CN109116023B (zh) * | 2018-06-14 | 2021-06-04 | 郑州大学第一附属医院 | 一种肺癌标志物抗-mmp12自身抗体及其应用 |
| JP7642530B2 (ja) | 2018-09-04 | 2025-03-10 | トレオス バイオ リミテッド | ペプチドワクチン |
| TW202039535A (zh) | 2018-12-18 | 2020-11-01 | 德商英麥提克生物技術股份有限公司 | B*08限制肽和肽組合物抗癌免疫治療和相關方法 |
| EP3739588A1 (en) * | 2019-05-13 | 2020-11-18 | Koninklijke Philips N.V. | Assessment of multiple signaling pathway activity score in airway epithelial cells to predict airway epithelial abnormality and airway cancer risk |
| CN110706742B (zh) * | 2019-09-30 | 2020-06-30 | 中生康元生物科技(北京)有限公司 | 泛癌种肿瘤新生抗原高通量预测方法及其应用 |
| CN111233972B (zh) * | 2020-01-19 | 2021-08-10 | 华南理工大学 | 一种抗炎三肽及其提取分离方法和在改善记忆中的应用 |
| CN111575283A (zh) * | 2020-04-20 | 2020-08-25 | 中山大学肿瘤防治中心 | Dkc1特异小干扰rna及其应用 |
| EP4192486A4 (en) * | 2020-08-07 | 2024-05-01 | The Broad Institute, Inc. | THERAPEUTIC TARGETING OF PHOSPHATE DISREGULATION IN CANCER VIA THE XPR1 PROTEIN COMPLEX: KIDINS220 |
| US12135375B2 (en) | 2020-10-23 | 2024-11-05 | Ford Global Technologies, Llc | Systems and methods for camera-LiDAR fused object detection with local variation segmentation |
| US11430224B2 (en) | 2020-10-23 | 2022-08-30 | Argo AI, LLC | Systems and methods for camera-LiDAR fused object detection with segment filtering |
| US11885886B2 (en) | 2020-10-23 | 2024-01-30 | Ford Global Technologies, Llc | Systems and methods for camera-LiDAR fused object detection with LiDAR-to-image detection matching |
| US12050273B2 (en) | 2020-10-23 | 2024-07-30 | Ford Global Technologies, Llc | Systems and methods for camera-LiDAR fused object detection with point pruning |
| US12118732B2 (en) | 2020-11-23 | 2024-10-15 | Ford Global Technologies, Llc | Systems and methods for object detection with LiDAR decorrelation |
| CN113185597B (zh) * | 2021-04-06 | 2022-08-23 | 中山大学孙逸仙纪念医院 | 一种可激活患者的抗肿瘤免疫反应的人肿瘤抗原及其应用 |
| CN113181350B (zh) * | 2021-04-27 | 2023-04-25 | 浙江大学 | 以活化成纤维fap为基础的肽类疫苗及其制备方法 |
| CN113136434A (zh) * | 2021-05-14 | 2021-07-20 | 北京化工大学 | Lpcat1基因在制备治疗癌症药物及诊断性试剂盒中的应用 |
| JP2024531419A (ja) * | 2021-08-20 | 2024-08-29 | ヒューニライフ バイオテクノロジー インコーポレイテッド | 線維性疾患の治療におけるアルファ－エノラーゼアンタゴニストの使用 |
| US20250134877A1 (en) * | 2021-09-09 | 2025-05-01 | Kartos Therapeutics | Methods of treating cancer dependent on myc gene expresssion |
| IT202100024779A1 (it) * | 2021-09-28 | 2023-03-28 | Univ Degli Studi Di Torino | Vaccino a DNA per l’uso nel trattamento profilattico o terapeutico dell’adenocarcinoma duttale pancreatico |
| CN113995841A (zh) * | 2021-11-04 | 2022-02-01 | 上海市胸科医院 | Mettl3/alkbh5/eno1调控轴作为靶位点在制备治疗肺腺癌药物中的应用 |
| CN116083434A (zh) * | 2021-11-08 | 2023-05-09 | 成都医学院 | 一种mcm5基因及其新用途 |
| US20250302930A1 (en) * | 2022-03-24 | 2025-10-02 | Institut Curie | Immunotherapy targeting tumor transposable element derived neoantigenic peptides in glioblastoma |
| CN114957399B (zh) * | 2022-06-29 | 2023-05-09 | 湖北工业大学 | 一种多肽、多肽衍生物及其在制备抗肿瘤药物中的应用 |
| CN116059361B (zh) * | 2023-02-27 | 2023-08-15 | 华中科技大学协和深圳医院 | 三价铬离子和/或金属铬在制备肿瘤免疫治疗药物中的应用 |
| CN116270523B (zh) * | 2023-05-15 | 2023-08-08 | 四川厌氧生物科技有限责任公司 | 一种耐酸的口服双层胶囊及其制备方法 |
| WO2026046995A1 (en) * | 2024-08-28 | 2026-03-05 | Pairx Bio Pte. Ltd | T cell receptors and uses thereof |
| CN121154672B (zh) * | 2025-11-21 | 2026-03-27 | 浙江省肿瘤医院 | Tmem43抑制剂在制备抗胃癌药物中的应用 |
Family Cites Families (73)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA92037A (en) | 1904-11-25 | 1905-03-07 | The Hooven, Owens, Rentchler Company | Turbine bearings |
| US4440859A (en) | 1977-05-27 | 1984-04-03 | The Regents Of The University Of California | Method for producing recombinant bacterial plasmids containing the coding sequences of higher organisms |
| US4704362A (en) | 1977-11-08 | 1987-11-03 | Genentech, Inc. | Recombinant cloning vehicle microbial polypeptide expression |
| LU88258I2 (https=) | 1978-12-22 | 1994-02-03 | ||
| US4530901A (en) | 1980-01-08 | 1985-07-23 | Biogen N.V. | Recombinant DNA molecules and their use in producing human interferon-like polypeptides |
| US4342566A (en) | 1980-02-22 | 1982-08-03 | Scripps Clinic & Research Foundation | Solid phase anti-C3 assay for detection of immune complexes |
| US4678751A (en) | 1981-09-25 | 1987-07-07 | Genentech, Inc. | Hybrid human leukocyte interferons |
| US4766075A (en) | 1982-07-14 | 1988-08-23 | Genentech, Inc. | Human tissue plasminogen activator |
| US4582800A (en) | 1982-07-12 | 1986-04-15 | Hoffmann-La Roche Inc. | Novel vectors and method for controlling interferon expression |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4757006A (en) | 1983-10-28 | 1988-07-12 | Genetics Institute, Inc. | Human factor VIII:C gene and recombinant methods for production |
| US4677063A (en) | 1985-05-02 | 1987-06-30 | Cetus Corporation | Human tumor necrosis factor |
| US4810648A (en) | 1986-01-08 | 1989-03-07 | Rhone Poulenc Agrochimie | Haloarylnitrile degrading gene, its use, and cells containing the gene |
| US4897445A (en) | 1986-06-27 | 1990-01-30 | The Administrators Of The Tulane Educational Fund | Method for synthesizing a peptide containing a non-peptide bond |
| US6252052B1 (en) | 1996-10-03 | 2001-06-26 | Cornell Research Foundation, Inc | Antibodies which bind to NY-ESO-1 cancer associated proteins, and hybridomas which produce these antibodies |
| ATE183513T1 (de) | 1993-06-03 | 1999-09-15 | Therapeutic Antibodies Inc | Herstellung von antikörperfragmenten |
| AUPM322393A0 (en) | 1993-12-24 | 1994-01-27 | Austin Research Institute, The | Mucin carbohydrate compounds and their use in immunotherapy |
| CA2243235C (en) | 1996-01-17 | 2010-08-10 | Imperial College Innovations Limited | Immunotherapy using cytotoxic t lymphocytes (ctl) |
| US5849589A (en) | 1996-03-11 | 1998-12-15 | Duke University | Culturing monocytes with IL-4, TNF-α and GM-CSF TO induce differentiation to dendric cells |
| US6406705B1 (en) | 1997-03-10 | 2002-06-18 | University Of Iowa Research Foundation | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
| US6221585B1 (en) * | 1998-01-15 | 2001-04-24 | Valigen, Inc. | Method for identifying genes underlying defined phenotypes |
| US20030236209A1 (en) * | 1998-03-18 | 2003-12-25 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
| US7579160B2 (en) | 1998-03-18 | 2009-08-25 | Corixa Corporation | Methods for the detection of cervical cancer |
| WO2000061779A1 (en) | 1999-04-09 | 2000-10-19 | Human Genome Sciences, Inc. | 49 human secreted proteins |
| US6703491B1 (en) * | 1999-03-17 | 2004-03-09 | Exelixis, Inc. | Drosophila sequences |
| CA2311201A1 (en) | 1999-08-05 | 2001-02-05 | Genset S.A. | Ests and encoded human proteins |
| EP1259545A2 (en) | 2000-01-21 | 2002-11-27 | Ludwig Institute For Cancer Research | Small cell lung cancer associated antigens and uses therefor |
| US20040191260A1 (en) | 2003-03-26 | 2004-09-30 | Technion Research & Development Foundation Ltd. | Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof |
| IL151860A0 (en) | 2000-03-27 | 2003-04-10 | Technion Res & Dev Foundation | Single chain class i major histocompatibility complexes, constructs encoding same and methods of generating same |
| AU7524601A (en) | 2000-06-05 | 2001-12-17 | Sunol Molecular Corp | T cell receptor fusions and conjugates and methods of use thereof |
| CA2443617C (en) * | 2001-04-17 | 2013-12-10 | The Board Of Trustees Of The University Of Arkansas | Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions |
| US7892559B2 (en) | 2002-01-30 | 2011-02-22 | Survac Aps | Survivin-derived peptides and use thereof |
| EP1332760A1 (en) * | 2002-02-04 | 2003-08-06 | Academisch Ziekenhuis Leiden | Novel epitopes for celiac disease and autoimmune diseases, methods for detecting those and novel non-antigenic food compounds |
| US6992176B2 (en) | 2002-02-13 | 2006-01-31 | Technion Research & Development Foundation Ltd. | Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease |
| AU2003216341A1 (en) | 2002-02-20 | 2003-09-09 | Dyax Corporation | Mhc-peptide complex binding ligands |
| CA2499123A1 (en) * | 2002-09-17 | 2004-04-15 | Antigen Express, Inc. | Ii-key/antigenic epitope hybrid peptide vaccines |
| AU2003267401A1 (en) * | 2002-10-02 | 2004-04-23 | F. Hoffmann-La Roche Ag | Novel mhc ii associated peptides |
| CA2501870C (en) | 2002-10-09 | 2013-07-02 | Avidex Limited | Single chain recombinant t cell receptors |
| PT1558643E (pt) | 2002-11-09 | 2009-08-24 | Immunocore Ltd | Apresentação de um receptor das células t |
| GB0304068D0 (en) | 2003-02-22 | 2003-03-26 | Avidex Ltd | Substances |
| JP4987698B2 (ja) * | 2005-03-31 | 2012-07-25 | 中外製薬株式会社 | 癌関連抗原アナログペプチド、およびその利用 |
| CN100393745C (zh) | 2005-05-27 | 2008-06-11 | 北京大学 | 一种肿瘤抗原蛋白质和肿瘤抗原肽 |
| EP1760089B1 (en) * | 2005-09-05 | 2009-08-19 | Immatics Biotechnologies GmbH | Tumor-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules and related anti-cancer vaccine |
| SI1806358T1 (sl) | 2005-09-05 | 2010-06-30 | Immatics Biotechnologies Gmbh | S tumorjem povezani peptidi ki se promiskuitetnovežejo na molekule humanega levkocitnega antigena HLA razreda II |
| WO2007103770A2 (en) * | 2006-03-02 | 2007-09-13 | Ppd Biomarker Discovery Sciences, Llc | Compositions and methods for analyzing renal cancer |
| AU2007284651B2 (en) * | 2006-08-09 | 2014-03-20 | Institute For Systems Biology | Organ-specific proteins and methods of their use |
| US8097242B2 (en) * | 2006-10-05 | 2012-01-17 | The Board Of Trustees Of The University Of Arkansas | Target CA125 peptides for cancer immunotherapy |
| CN103864893B (zh) | 2007-07-27 | 2017-01-04 | 伊玛提克斯生物技术有限公司 | 免疫疗法的免疫抗原表位 |
| KR20100075483A (ko) | 2007-09-20 | 2010-07-02 | 더 제이. 데이비드 글래드스톤 인스티튜트 | 장산재 핵 요소 폴리펩티드 조성물 및 그것의 사용방법 |
| EP3115469B1 (en) | 2007-11-19 | 2020-04-29 | Celera Corporation | Lung cancer markers and uses thereof |
| WO2009075883A2 (en) | 2007-12-12 | 2009-06-18 | University Of Georgia Research Foundation, Inc. | Glycoprotein cancer biomarker |
| WO2009126805A2 (en) | 2008-04-11 | 2009-10-15 | The Board Of Regents Of The Univeristy Of Texas System | Therapeutic tarageting of mmps in neutral liposomes |
| US20090263574A1 (en) | 2008-04-21 | 2009-10-22 | Quinn Daniel E | Method of restoring an article |
| ITMI20081119A1 (it) * | 2008-06-19 | 2009-12-20 | Menarini Internat Operation Luxembourg Sa | Frammenti di muc16 ad attivita antigenica e composizioni farmaceutiche che li contengono |
| AU2010248380B2 (en) * | 2009-05-15 | 2013-12-19 | Nec Solution Innovators, Ltd. | Aptamer that recognizes peptide |
| CA2772551A1 (en) | 2009-08-26 | 2011-03-03 | Immunotope, Inc. | Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer |
| GB201004551D0 (en) * | 2010-03-19 | 2010-05-05 | Immatics Biotechnologies Gmbh | NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer |
| GB201004575D0 (en) * | 2010-03-19 | 2010-05-05 | Immatics Biotechnologies Gmbh | Composition of tumor associated peptides and related anti cancer vaccine for the treatment of gastric cancer and other cancers |
| GB201019331D0 (en) * | 2010-03-19 | 2010-12-29 | Immatics Biotechnologies Gmbh | Methods for the diagnosis and treatment of cancer based on AVL9 |
| EP4012714A1 (en) * | 2010-03-23 | 2022-06-15 | Iogenetics, LLC. | Bioinformatic processes for determination of peptide binding |
| GB201006360D0 (en) | 2010-04-16 | 2010-06-02 | Immatics Biotechnologies Gmbh | Method for differentially quantifying naturally processed HLA-restricted peptides for cancer, autoimmune and infectious diseases immunotherapy development |
| EP2569633B1 (en) | 2010-05-14 | 2016-02-10 | The General Hospital Corporation | Compositions and methods of identifying tumor specific neoantigens |
| WO2012048291A2 (en) | 2010-10-08 | 2012-04-12 | Proteapex Therapeutics Llc | Compositions and methods for inhibition of mmp:mmp-substrate interactions |
| EP2632955A1 (en) | 2010-10-26 | 2013-09-04 | Technion Research & Development Foundation Ltd. | Antibodies which bind soluble t-cell receptor ligands |
| WO2012100023A1 (en) | 2011-01-19 | 2012-07-26 | Thomas Jefferson University | Detection of pancreatic ductal adenocarcinoma |
| WO2013034741A1 (en) | 2011-09-07 | 2013-03-14 | Midatech Limited | Nanoparticle tumour vaccines |
| WO2013057586A1 (en) | 2011-10-19 | 2013-04-25 | Oslo Universitetssykehus Hf | Compositions and methods for producing soluble t - cell receptors |
| ES2603589T3 (es) | 2012-11-08 | 2017-02-28 | F. Hoffmann-La Roche Ag | Ácidos nucleicos que codifican polipéptidos quiméricos para la identificación sistemática de bibliotecas |
| TWI643867B (zh) | 2013-05-24 | 2018-12-11 | 日商腫瘤療法 科學股份有限公司 | 對於ｔｈ１細胞之ｉｍｐ－３抗原決定位胜肽及含此之疫苗 |
| EP2808392A1 (en) | 2013-05-28 | 2014-12-03 | Rheinische Friedrich-Wilhelms-Universität Bonn | Aptamers and use of the aptamers in the diagnosis and treatment of cancer |
| TWI636065B (zh) | 2013-08-05 | 2018-09-21 | 伊瑪提克斯生物科技有限公司 | 新穎肽類，細胞及其用於治療多種腫瘤的用途，其製造方法及包含其等之醫藥組成物 |
| MY189596A (en) * | 2015-07-15 | 2022-02-18 | Immatics Biotechnologies Gmbh | A novel peptides for use in immunotherapy against epithelial ovarian cancer and other cancers |
| GB201515321D0 (en) * | 2015-08-28 | 2015-10-14 | Immatics Biotechnologies Gmbh | Novel peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers |
-
2015
- 2015-04-24 GB GBGB1507030.3A patent/GB201507030D0/en not_active Ceased
-
2016
- 2016-04-22 CN CN201680023017.6A patent/CN107624118B/zh not_active Expired - Fee Related
- 2016-04-22 EP EP20179384.1A patent/EP3750559A1/en not_active Withdrawn
- 2016-04-22 MA MA051763A patent/MA51763A/fr unknown
- 2016-04-22 RU RU2017137142A patent/RU2723092C2/ru active
- 2016-04-22 CN CN202011636460.5A patent/CN113045642A/zh active Pending
- 2016-04-22 MA MA051762A patent/MA51762A/fr unknown
- 2016-04-22 MA MA051761A patent/MA51761A/fr unknown
- 2016-04-22 AU AU2016251621A patent/AU2016251621B2/en not_active Ceased
- 2016-04-22 PE PE2022002861A patent/PE20230768A1/es unknown
- 2016-04-22 CN CN202011636461.XA patent/CN112661838A/zh active Pending
- 2016-04-22 TW TW105112670A patent/TWI737605B/zh not_active IP Right Cessation
- 2016-04-22 EP EP20179382.5A patent/EP3750557A1/en not_active Withdrawn
- 2016-04-22 SG SG11201704966YA patent/SG11201704966YA/en unknown
- 2016-04-22 CA CA2983064A patent/CA2983064A1/en active Pending
- 2016-04-22 IL IL292411A patent/IL292411A/en unknown
- 2016-04-22 SG SG10202001482YA patent/SG10202001482YA/en unknown
- 2016-04-22 KR KR1020177030445A patent/KR20170137119A/ko active Pending
- 2016-04-22 EA EA201792044A patent/EA201792044A1/ru unknown
- 2016-04-22 RU RU2020113032A patent/RU2020113032A/ru unknown
- 2016-04-22 UA UAA201705953A patent/UA122675C2/uk unknown
- 2016-04-22 AR ARP160101140A patent/AR104675A1/es not_active Application Discontinuation
- 2016-04-22 PE PE2017001272A patent/PE20171765A1/es unknown
- 2016-04-22 MY MYPI2017702617A patent/MY173099A/en unknown
- 2016-04-22 WO PCT/EP2016/059053 patent/WO2016170139A1/en not_active Ceased
- 2016-04-22 EP EP20179383.3A patent/EP3750558A1/en not_active Withdrawn
- 2016-04-22 MA MA041939A patent/MA41939A/fr unknown
- 2016-04-22 CN CN202011636463.9A patent/CN112679604A/zh active Pending
- 2016-04-22 EP EP16717663.5A patent/EP3285801A1/en not_active Withdrawn
- 2016-04-22 MA MA052115A patent/MA52115A/fr unknown
- 2016-04-22 BR BR112017017560-6A patent/BR112017017560A2/pt not_active IP Right Cessation
- 2016-04-22 US US16/305,686 patent/US10925948B2/en not_active Expired - Fee Related
- 2016-04-22 EP EP20179381.7A patent/EP3760225A3/en not_active Withdrawn
- 2016-04-22 HK HK18103193.9A patent/HK1244666A1/zh unknown
- 2016-04-22 NZ NZ734197A patent/NZ734197A/en not_active IP Right Cessation
- 2016-04-22 TW TW110112383A patent/TW202130658A/zh unknown
- 2016-04-22 MX MX2017013688A patent/MX2017013688A/es unknown
- 2016-04-22 JP JP2017548292A patent/JP6901065B2/ja not_active Expired - Fee Related
-
2017
- 2017-07-12 PH PH12017501275A patent/PH12017501275A1/en unknown
- 2017-07-12 CL CL2017001819A patent/CL2017001819A1/es unknown
- 2017-07-20 ZA ZA2017/04939A patent/ZA201704939B/en unknown
- 2017-08-30 CO CONC2017/0008902A patent/CO2017008902A2/es unknown
- 2017-09-24 IL IL254626A patent/IL254626A0/en unknown
- 2017-10-24 MX MX2022005060A patent/MX2022005060A/es unknown
-
2019
- 2019-05-23 AU AU2019203625A patent/AU2019203625B2/en not_active Ceased
- 2019-07-23 US US16/520,003 patent/US10526389B2/en active Active
- 2019-07-23 US US16/519,959 patent/US10577402B2/en active Active
- 2019-07-23 US US16/519,987 patent/US10550167B2/en active Active
- 2019-12-13 US US16/714,112 patent/US10662233B2/en active Active
-
2020
- 2020-04-13 CL CL2020000984A patent/CL2020000984A1/es unknown
- 2020-04-13 CL CL2020000986A patent/CL2020000986A1/es unknown
- 2020-04-13 CL CL2020000983A patent/CL2020000983A1/es unknown
- 2020-04-13 CL CL2020000985A patent/CL2020000985A1/es unknown
- 2020-04-13 CL CL2020000989A patent/CL2020000989A1/es unknown
- 2020-04-13 CL CL2020000988A patent/CL2020000988A1/es unknown
- 2020-04-13 CL CL2020000987A patent/CL2020000987A1/es unknown
- 2020-06-29 US US16/915,707 patent/US10898559B2/en active Active
- 2020-08-24 AU AU2020223638A patent/AU2020223638B2/en not_active Ceased
- 2020-08-24 AU AU2020223637A patent/AU2020223637B2/en not_active Ceased
- 2020-08-24 AU AU2020223639A patent/AU2020223639B2/en not_active Ceased
- 2020-09-11 US US17/018,572 patent/US10898560B2/en not_active Expired - Fee Related
- 2020-12-09 US US17/116,845 patent/US11027002B2/en active Active
-
2021
- 2021-01-15 US US17/150,617 patent/US11071773B2/en not_active Expired - Fee Related
- 2021-05-17 AU AU2021203138A patent/AU2021203138B2/en not_active Ceased
- 2021-05-21 US US17/327,193 patent/US20210275655A1/en not_active Abandoned
- 2021-05-24 JP JP2021087277A patent/JP7525442B2/ja active Active
- 2021-10-15 US US17/502,686 patent/US11324812B2/en active Active
-
2022
- 2022-02-25 US US17/681,447 patent/US20220184194A1/en not_active Abandoned
- 2022-02-25 US US17/681,268 patent/US20220184193A1/en not_active Abandoned
- 2022-03-04 US US17/687,274 patent/US20220193212A1/en not_active Abandoned
- 2022-03-04 US US17/687,297 patent/US20220313805A1/en not_active Abandoned
- 2022-03-11 US US17/692,264 patent/US20220211833A1/en not_active Abandoned
-
2024
- 2024-03-06 JP JP2024034009A patent/JP2024069322A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018518937A5 (https=) | ||
| JP2018511321A5 (https=) | ||
| JP2018519243A5 (https=) | ||
| JP2018529320A5 (https=) | ||
| JP2021168652A5 (https=) | ||
| JP2018510628A5 (https=) | ||
| JP2018521641A5 (https=) | ||
| JP2019510465A5 (https=) | ||
| JP2018536383A5 (https=) | ||
| JP2019502360A5 (https=) | ||
| JP2018520653A5 (https=) | ||
| JP2018518956A5 (https=) | ||
| JP2019506838A5 (https=) | ||
| JP2018509135A5 (https=) | ||
| RU2017137142A (ru) | Новые пептиды и комбинации пептидов для применения в иммунотерапии рака легких, в том числе немелкоклеточного рака легких (нмрл) и других видов рака | |
| JP2021514178A5 (https=) | ||
| JP2019511214A5 (https=) | ||
| JP2017525336A5 (https=) | ||
| JP2017502076A5 (https=) | ||
| JP2024041841A5 (https=) | ||
| JP2024099580A5 (https=) | ||
| JP5393144B2 (ja) | Ｈｌａ−ａ＊３３０３拘束性ｗｔ１ペプチド、およびそれを含む医薬組成物 | |
| JP2018519825A5 (https=) | ||
| AR106920A1 (es) | Péptidos y combinaciones de péptidos para el uso en la inmunoterapia contra la leucemia linfocítica crónica (llc) y otros tipos de cáncer | |
| JP2021535900A5 (https=) |